Suppression of Alcohol Delirium Tremens by Baclofen Administration: A Case Report
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Delirium tremens (DT) is a clinical condition that appears in some patients affected by severe alcohol withdrawal syndrome (AWS). DT represents a serious complication, being characterized by elevated morbidity and mortality. Benzodiazepines are presently the drug of choice; however their use is related to several side effects. Baclofen is a stereoselective gamma-aminobutyric acid (GABAB) receptor agonist. Recent studies show that baclofen is able to suppress alcohol withdrawal symptoms. At present there are no data on the effects of baclofen administration in AWS complicated by DT. Here, we report a case of DT successfully treated with baclofen. This result indicates that the efficacy of baclofen in the treatment of DT should be examined in future clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SULLIVAN, J. T., SYKORA, K., SCHNEIDERMAN, J., NARANJO, C. A., & SELLERS, E. M. (1989) · British Journal of Addiction · doi:10.1111/j.1360-0443.1989.tb00737.x · Cited by 1,988
Mayo-Smith, M. F. (1997) · JAMA · doi:10.1001/jama.278.2.144 · Cited by 434 · cited 1×
“However, the use of benzodiazepines is related to several side effects, such as the risk of high sedation, respiratory depression, and liver impairment in patients still affected by alcoholic liver disease, and addictive properties particularly in subjects affected by substance abuse.(19,20) The discovery of new drugs…”
BackgroundAlcohol withdrawal syndromes: A review of pathophysiology, clinical presentation, and treatment
Turner, R. C., Lichstein, P. R., Peden, J. G., Busher, J. T., & Waivers, L. E. (1989) · Journal of General Internal Medicine · doi:10.1007/bf02599697 · Cited by 108
Cited by
Garbutt, J. C., Kampov‐Polevoy, A. B., Gallop, R., Kalka‐Juhl, L., & Flannery, B. A. (2010) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01273.x · Cited by 294
Baclofen in the Treatment of Alcohol Withdrawal Syndrome: A Comparative Study vs Diazepam
Addolorato, G., Leggio, L., Abenavoli, L., Agabio, R., Caputo, F., Capristo, E., Colombo, G., Gessa, G. L., & Gasbarrini, G. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.08.042 · Cited by 203
Self-citationThe Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective
de Beaurepaire, R., Sinclair, J. M. A., Heydtmann, M., Addolorato, G., Aubin, H.-J., Beraha, E. M., Caputo, F., Chick, J. D., de La Selle, P., Franchitto, N., et al. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00708 · Cited by 95
Self-citationBaclofen for alcohol withdrawal
Liu, J., & Wang, L.-N. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008502.pub4 · Cited by 26
Baclofen and the Alcohol Withdrawal Syndrome—A Short Review
Cooney, G., Heydtmann, M., & Smith, I. D. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00773 · Cited by 24
Metadata
- Authors
- Addolorato, G., Leggio, L., Abenavoli, L., DeLorenzi, G., Parente, A., Caputo, F., Janiri, L., Capristo, E., Rapaccini, G. L., & Gasbarrini, G.
- Venue
- Clinical Neuropharmacology
- Published
- 2003-09
- Volume
- 26
- Issue
- 5
- Pages
- 258-262
- ISSN
- 0362-5664 (ISSN-L)
- OpenAlex
- W1975490152
- Cited by
- 58
- References
- 3
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Suppression of Alcohol Delirium Tremens by Baclofen Administration: A Case Report. https://app.cochat.ai/papers/10.1097/00002826-200309000-00010
- The paper
- Addolorato, G., Leggio, L., Abenavoli, L., DeLorenzi, G., Parente, A., Caputo, F., Janiri, L., Capristo, E., Rapaccini, G. L., & Gasbarrini, G. (2003). Suppression of Alcohol Delirium Tremens by Baclofen Administration: A Case Report. Clinical Neuropharmacology. https://doi.org/10.1097/00002826-200309000-00010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.